If the FDA took into consideration where a company is located,...

If the FDA took into consideration where a company is located, rather than its fundamentals, or rather the benefits a product can have to the people within the USA, then I'd say the FDA has no credibility. I'm am 100% sure this isn't the case!

The delay to the start of phase 3 for Revascor is annoying I admit, especially without any reasoning being announced by the company. But I'm not concerned about the investment I have in MSB as it's just a waiting game.

Mesoblast have the science, the patents and the brilliant minds of Silvio and his colleagues. It's just a matter of time before breaking into the market with an FDA approved product. It will start with Revascor, but no one really knows where or if the list of products MSB will deliver will ever end. Not only will the many products bring revenue to the company, but health benefits for the globe. To me this stock is a sit and hold for a lifetime.